RetinalGenix Technologies Inc
OTC:RTGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
RetinalGenix Technologies Inc
OTC:RTGN
|
US |
|
Intercos SpA
OTC:ICOSF
|
IT |
|
M
|
Medite Cancer Diagnostics Inc
OTC:MDIT
|
US |
|
Adacel Technologies Ltd
ASX:ADA
|
AU |
|
Queen's Road Capital Investment Ltd
F:47U
|
HK |
|
H
|
Hepion Pharmaceuticals Inc
F:336P
|
US |
|
ActivePort Group Ltd
ASX:ATV
|
AU |
|
V
|
Visiber57 Corp
OTC:VCOR
|
TW |
|
I
|
IDS SA
PAR:MLIDS
|
FR |
|
M
|
Matrix Service Co
SWB:MX2
|
US |
|
G
|
Guangdong Land Holdings Ltd
F:GUW
|
HK |
|
Emperor Energy Ltd
ASX:EMP
|
AU |
|
Extreme Biodiesel Inc
OTC:XTRM
|
US |
|
P
|
PinkMonkey.com Inc
OTC:PMKY
|
US |
Bankruptcy Probability
RetinalGenix Technologies Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
RetinalGenix Technologies Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
RetinalGenix Technologies Inc
OTC:RTGN
|
75m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
224.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
475.1B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
30.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
26.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
25.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|
24.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
23.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
RetinalGenix Technologies Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, RetinalGenix Technologies Inc has total debt of 49k USD. This includes both short-term (49k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
